Avalon GloboCare Corp. (NASDAQ: ALBT)

Avalon GloboCare Corp. operates as a technology-focused company with a strategic emphasis on developing innovative consumer health and Agentic AI products. The company targets both consumers and small businesses, adapting its business model in response to market conditions and commercial opportunities. Avalon GloboCare Corp. is actively seeking complementary bolt-on AI acquisitions to generate near-term revenue and supplement its current operations.

The company generates revenue through two primary business segments: a consumer health technology segment and an artificial intelligence software segment. The consumer health technology segment distributes the Keto Air breathalyzer device, a non-invasive consumer breathalyzer that measures ketosis levels. This device is sold in North America and bears an FDA registration number. The artificial intelligence software segment develops and commercializes an AI-driven, short-form video generation platform operated by Avalon Quantum AI, LLC, a wholly owned subsidiary formed through the acquisition of RPM Interactive, Inc. in December 2025.

• Consumer Health Technology Segment: This segment centers on the Keto Air breathalyzer device, a non-invasive consumer health product that allows users to determine their state of nutritional ketosis by exhaling into a compact, pen-like breathalyzer. The Keto Air device represents a significant improvement over prior methods of measuring ketosis, offering users a convenient, reusable, and non-invasive testing experience. Avalon GloboCare Corp. holds exclusive distribution rights for the Keto Air technology and device in North America through July 2025. The company previously developed a THC breathalyzer device but discontinued it due to a lack of available funding. The Keto Air device is marketed through social media influencer relationships and a commercial relationship with the Law Enforcement Association of America. The device is currently in an early-stage commercial testing phase, with the company assessing broader market demand and refining its distribution and marketing approach. The Keto Air device bears an FDA registration number, which is required for its commercial sale in the United States. It is classified as a consumer product and not a regulated medical device, allowing for direct sales to consumers without a prescription or other regulatory authorization.

• Artificial Intelligence Software Segment: This segment is operated through Avalon Quantum AI, LLC, a wholly owned subsidiary formed through the acquisition of RPM Interactive, Inc. The segment focuses on advancing next-generation Agentic AI systems, including automated video generation, small business marketing, and workflow automation solutions. The Catch-Up platform is an AI-driven, short-form video generation software product currently in beta testing with a limited number of content creators. The platform enables content creators, initially focusing on the podcasting market, to input a topic and automatically generate a structured, short-form video featuring an AI-generated avatar of the creator. The platform is designed to automate the time-consuming process of identifying and sourcing video content, writing scripts, and producing recordings, enabling creators to generate daily content at scale. Phase 2 of the Catch-Up platform is expected to launch in Q3 2026, transitioning the platform into a fully autonomous, agentic AI-driven video platform. This phase will expand the platform's user base beyond podcasters to a broader range of content creators and marketers, including social media influencers and individuals or businesses engaged in product marketing and e-commerce.

Avalon GloboCare Corp. operates in two distinct and competitive markets. In the consumer health technology segment, the company competes with manufacturers and distributors of urine-based ketone test strips and other breath-based ketone monitoring devices. The Keto Air device competes favorably on the basis of its reusable design, ease of use, and the convenience of non-invasive breath-based testing relative to urine strip alternatives. As the sole distributor of the Keto Air device in North America, the company enjoys a meaningful structural advantage. However, many competitors in this space have significantly greater financial resources, brand recognition, established retail distribution networks, and marketing infrastructure.

In the artificial intelligence software segment, Avalon GloboCare Corp. competes with a broad range of companies offering AI-powered video generation, content automation, and creator economy tools. Key competitive factors in this market include the quality and realism of AI-generated content, the breadth of the platform's addressable user base, the speed and automation of content generation workflows, the sophistication of voice and likeness replication technology, integration with major social media and content distribution platforms, and the ability to scale rapidly to meet growing creator demand. The company believes its Catch-Up platform competes on the basis of its end-to-end automation of the video content creation process. However, many competitors in the generative AI space have substantially greater financial resources, research and development capabilities, engineering talent, data assets, and market presence.

The general customer base for Avalon GloboCare Corp. includes consumers interested in monitoring their ketosis levels and content creators, particularly those in the podcasting market, who seek efficient tools for generating high-quality content. The company's commercial relationship with the Law Enforcement Association of America highlights the relevance of metabolic health monitoring to the wellness programs of law enforcement personnel and their families. As the Catch-Up platform expands, it aims to cater to a broader range of content creators and marketers, including social media influencers and businesses engaged in product marketing and e-commerce.